Out-of-pocket costs for patients with psoriasis in an outpatient dermatology referral service
- PMID: 33775478
- PMCID: PMC8178524
- DOI: 10.1016/j.abd.2020.09.004
Out-of-pocket costs for patients with psoriasis in an outpatient dermatology referral service
Abstract
Background: Psoriasis is a chronic disease that derives great costs to the health care system. In Colombia, due to deficiencies in this system, patients are more likely to incur in out-of-pocket expenses; money that has never been quantified in this country.
Objectives: To quantify out-of-pocket expenses and to analyze their relation to patients' clinical and labor characteristics in a cohort of psoriatic patients.
Methods: A single-center, cross-sectional study was performed, evaluating psoriasis patients.
Results: A total of 100 psoriasis patients were analyzed. We identified that patients with higher dermatology life quality index and in phototherapy treatment were the ones that had higher out-of-pocket costs (p = 0.006 and 0.005, respectively). We found no correlation between out-of-pocket costs and occupational status, psoriasis area severity index or other types of treatment. The largest amount of money was used to buy medications and bus transportation with a maximum up to 440.50 and 528.60 USD, respectively. Among the 100 participants the total expense was 11131.90 USD in a 6-month period.
Study limitations: Lack of measurement of the labor productivity and labor absenteeism secondary to sick leave.
Conclusion: Out-of-pocket costs are similar with what was shown in previous studies. We found statistically significant differences for the DLQI in comparison with out-of-pocket expenses, regardless of the PASI level. Phototherapy treatment also had statistically significant differences in relationship with out-of-pocket expenses, when compared to other treatments, because it requires higher expenses in transportation, copayments, and alimentation during appointment assistance.
Keywords: Health care costs; Health expenditures; Psoriasis.
Copyright © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.Int J Dermatol. 2013 Mar;52(3):314-22. doi: 10.1111/j.1365-4632.2011.05340.x. Int J Dermatol. 2013. PMID: 23414155
-
Severity and management of psoriasis within primary care.BMC Fam Pract. 2016 Oct 14;17(1):145. doi: 10.1186/s12875-016-0544-6. BMC Fam Pract. 2016. PMID: 27737638 Free PMC article.
-
Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).J Eur Acad Dermatol Venereol. 2015 Mar;29(3):452-6. doi: 10.1111/jdv.12576. Epub 2014 Jun 9. J Eur Acad Dermatol Venereol. 2015. PMID: 24911993
-
Cost effectiveness of biologic therapies for plaque psoriasis.Am J Clin Dermatol. 2013 Aug;14(4):315-26. doi: 10.1007/s40257-013-0030-z. Am J Clin Dermatol. 2013. PMID: 23696234 Review.
-
Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity.Crit Rev Oncol Hematol. 2021 Nov;167:103501. doi: 10.1016/j.critrevonc.2021.103501. Epub 2021 Oct 18. Crit Rev Oncol Hematol. 2021. PMID: 34673219 Review.
Cited by
-
Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey.Int J Dermatol. 2025 Feb;64(2):325-332. doi: 10.1111/ijd.17387. Epub 2024 Jul 17. Int J Dermatol. 2025. PMID: 39021244 Free PMC article.
-
Out-of-pocket and catastrophic health expenditure among patients of sexually transmitted infections at a tertiary care center: A cross-sectional study.Indian J Sex Transm Dis AIDS. 2024 Jan-Jun;45(1):25-30. doi: 10.4103/ijstd.ijstd_56_23. Epub 2024 Jun 6. Indian J Sex Transm Dis AIDS. 2024. PMID: 38989093 Free PMC article.
-
The Skin and Natural Cannabinoids-Topical and Transdermal Applications.Pharmaceuticals (Basel). 2023 Jul 24;16(7):1049. doi: 10.3390/ph16071049. Pharmaceuticals (Basel). 2023. PMID: 37513960 Free PMC article. Review.
References
-
- Stawowcyk E., Malinowski K.P., Kawalec P., Moćko P. The indirect costs of multiple sclerosis: systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15:759–786. - PubMed
-
- Mehrmal S., Uppal P., Nedley N., Giesey R.L., Delost G.R. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol. 2021;84:46–52. - PubMed
-
- Schaefer C.P., Cappelleri J.C., Cheng R., Cole J.C., Guenthner S., Fowler J. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States. J Am Acad Dermatol. 2015;73:e3.585–593.e3. - PubMed
-
- Palacios-Barahona U., Jiménezez S.B., Orozco J.J. Clinical characteristics, utilization of resources and costs of patients with psoriasis in a medical center referenced in el Valle de Aburrá, 2014. Rev Asoc Colomb Dermatol. 2014;24:253–263.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical